Millennium Management
TTRX

Millennium Management’s Turn Therapeutics TTRX Stock Holding History

Millennium Management’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Sell
69,757
-25,866
-27% -$101K ﹤0.01% 5136
2025
Q4 		$377K Buy
+95,623
New +$399K ﹤0.01% 5122

Other funds holding TTRX

DI
DDFG Inc Thousand Oaks, California $464M AUM 16.56% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $7.29B AUM 16.22% 1-Year Est. Return

Millennium Management's TTRX Position: Q1 2026 in Review

Millennium Management reduced its Turn Therapeutics (TTRX) stake by 27% in Q1 2026, selling an estimated $101K and leaving 69,757 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #5136.

Millennium Management first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $377K in Q4 2025. 20 funds tracked by Wall St. Rank hold TTRX as of Q1 2026.

  • Millennium Management held 69,757 shares of Turn Therapeutics worth $223K as of Q1 2026.
  • Millennium Management sold 25,866 Turn Therapeutics shares in Q1 2026, an estimated $101K.
  • Turn Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #5136 holding.
  • Millennium Management first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Millennium Management's Turn Therapeutics position peaked at $377K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.